PATH EX, Inc.
PrivateLast Round
Series A
Apr 25, 2025
Total Funding Raised
$6.88M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PATH EX, Inc. is a medical device company developing CycloPE®, a blood purification device designed to directly capture and remove bacteria from the bloodstream to treat sepsis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PATH EX, Inc. Comparables
Compare PATH EX, Inc. with similar companies based on industry and business-model similarity.
PATH EX, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 25, 2025 | ||||
| Grant | Sep 23, 2021 | ||||
| Seed | Oct 1, 2020 | ||||
| Grant | Jun 1, 2018 | ||||
| Grant | Jul 1, 2017 |
Key People
Founding team and executive leadership
PATH EX, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| IAG Capital Partners | Series A |
| ZeroTo510 | Accelerator |
| MassChallenge | Seed |
| Texas Medical Center | Series A |
| AdvaMed Accel | Grant |
| Fitz Gate Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 152% MoM, reaching 1K.
- Jun 1, 2018
Received $910K from the National Science Foundation.
PATH EX, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PATH EX, Inc.'s valuation, stock price, and market status.